As the only FDA-approved oral octreotide capsule for long-term medical treatment of acromegaly, the Mycapssa® twice-daily oral capsule suggests a new opportunity for at-home long-term management of GH and IGF-1 levels in patients with acromegaly [5,6]. This evidence concerns the gene GH1 and acromegaly.